John A Zebala

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 5

Top Topics

Dendritic Cells

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Saifun Nahar, Yue Huang, Bethany A Nagy, John A Zebala, Dean Y Maeda, Udo Rudloff, Joost J Oppenheim, De Yang
Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies. Cancers 15 (8) (2023)
Saifun Nahar, Yue Huang, Bethany A Nagy, John A Zebala, Dean Y Maeda, Udo Rudloff, Joost J Oppenheim, De Yang
Regression and Eradication of Triple-Negative Breast Carcinoma in 4T1 Mouse Model by Combination Immunotherapies. Cancers 15 (8) (2023)
Lucas A Horn, Kristen Fousek, Duane H Hamilton, James W Hodge, John A Zebala, Dean Y Maeda, Jeffrey Schlom, Claudia Palena
Vaccine Increases the Diversity and Activation of Intratumoral T Cells in the Context of Combination Immunotherapy. Cancers 13 (5) (2021)
Kwan Ho Tang, Shuai Li, Alireza Khodadadi-Jamayran, Jayu Jen, Han Han, Kayla Guidry, Ting Chen, Yuan Hao, Carmine Fedele, John A Zebala, Dean Y Maeda, James G Christensen, Peter Olson, Argus Athanas, Cynthia A Loomis, Aristotelis Tsirigos, Kwok-Kin Wong, Benjamin G Neel
Combined Inhibition of SHP2 and CXCR1/2 Promotes Anti-Tumor T Cell Response in NSCLC. Cancer discovery (2021)
Sarah Greene, Yvette Robbins, Wojciech K Mydlarz, Angel P Huynh, Nicole C Schmitt, Jay Friedman, Lucas A Horn, Claudia Palena, Jeffrey Schlom, Dean Y Maeda, John A Zebala, Paul E Clavijo, Clint Allen
Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (6) (2019)